Jutta Proba

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Manuel Schmidt, Stefan Nagel, Jutta Proba et al. · Blood · 1998 · 200 citations

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

Karin Schmelz, Joern Toedling, Matthew R. Huska et al. · Nature Communications · 2021 · 94 citations · Full text

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma

Viktor Arnhold, Karin Schmelz, Jutta Proba et al. · Oncotarget · 2017 · 83 citations · Full text

Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia

Cornelia Eckert, Olfert Landt, Tillmann Taube et al. · Leukemia · 2000 · 66 citations

Hematological Malignancy, Engineering, Pediatric Hematology +12

Expression of Interferon Regulatory Factor 4 in Chronic Myeloid Leukemia: Correlation With Response to Interferon Alfa Therapy

Manuel Schmidt, Andreas Hochhaus, Sven A. König-Merediz et al. · Journal of Clinical Oncology · 2000 · 47 citations